Topical ophthalmic administration of the antiangiogenic peptide VIAN-c4551 protects against experimental diabetic macular edema.
Saved in:
| Title: | Topical ophthalmic administration of the antiangiogenic peptide VIAN-c4551 protects against experimental diabetic macular edema. |
|---|---|
| Authors: | Adán-Castro, Elva1 (AUTHOR), Zamora, Magdalena1 (AUTHOR), Granados-Carrasco, Daniela1 (AUTHOR), Siqueiros-Márquez, Lourdes1 (AUTHOR), García-Rodrigo, Jose F.1 (AUTHOR), Macias, Fernando1 (AUTHOR), Bertsch, Thomas2 (AUTHOR), Triebel, Jakob2 (AUTHOR), Arnold, Edith1,3 (AUTHOR), Martínez de la Escalera, Gonzalo1 (AUTHOR), Robles, Juan Pablo1,4 (AUTHOR) jp.robles@viantx.com, Clapp, Carmen1 (AUTHOR) clapp@unam.mx |
| Source: | Scientific Reports. 7/23/2025, Vol. 15 Issue 1, p1-12. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
